Dear Client,
As part of our ongoing commitment to ensuring the security of your online trading experience, we would like to inform you of our protocol for addressing any suspicious activities observed on your trading account
Should you notice any irregularities or suspect unauthorized access to your account, we kindly request that you take immediate action by following the steps outlined below:
Send an Email Please send an email to stoptrade@acml.in from your registered email ID. In the email, briefly outline the suspicious activity you have observed.
Phone Call Alternatively, you can call us at 07965081981 Ext: 4 from your registered mobile number. This will enable us to address your concerns promptly.
When contacting us, please ensure you provide the following details:
By providing this information, you enable us to swiftly investigate and take appropriate measures to safeguard your account.
Your security and peace of mind are of utmost importance to us, and we appreciate your cooperation in maintaining the integrity of your trading account.
The company's foray into crop nutrition aligns with its Vision 2026 growth strategy. It has set a target to achieve total turnover of Rs 2,500 crore in the current fiscal year. Additionally, Heranba plans to expand its presence to over 80 countries and is looking to establish a subsidiary in Dubai to strengthen its footprint in the Middle East and Africa. The company also aims to leverage its seven manufacturing facilities and scale up its contract manufacturing organization (CMO) operations to enhance capacity utilization and build brand equity.
R. K. Shetty, managing director of Heranba Industries, said, 'The crop nutrition segment is witnessing a strong CAGR of over 15% globally and in India. Our entry into this space is a natural strategic progression. We are targeting accelerated growth from this segment over the next three years. By integrating global R & D with our manufacturing strengths, we aim to deliver world-class, sustainable solutions to farmers.'
Heranba Industries is engaged in the manufacture of synthetic pyrethroids and their intermediates. The company has an integrated presence across the agrochemical value chain, spanning technicals to formulations, and focuses on enhancing crop productivity while supporting global food security initiatives.
The company reported consolidated net loss of Rs 23.25 crore in Q3 FY26 compared with net loss of Rs 10.19 crore in Q3 FY25. Net sales declined 11.7% YoY to Rs 301.37 crore in Q3 FY26.